The Cancer Institute is a leader in cutting-edge treatments. Using a truly multidisciplinary approach, patients have access to advanced diagnostics, minimally invasive surgical interventions, and personalized genomic and immune-oncologic treatment options. Our team of cancer specialists – many of whom completed fellowships and specialty training at prestigious academic centers – offers comprehensive services for individuals with a cancer diagnosis.

Follow

Submissions from 2013

Link

Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types, Partha S. Ray, Sanjay Bagaria, Xiaojiang Cui, and Jinhua Wang

Link

Method for enhancing specific immunotherapies in cancer treatment, Peter G. Traber, William L. Redmond, Eliezer Zomer, Anatole Klyosov, and Stefanie N. Linch

Link

Molecular malignancy in melanocytic lesions, Hui Wang, Christopher Roberts, Krishna Maddula, Zhenquiang Lu, Tom Vasicek, BJ Kerns, Bruce E. Seligmann, and Dave S B Hoon

Link

Elucidation of the molecular interaction between cisplatin and flavonol(s) and their effect on DNA binding., Theodore J Zwang, Kavisha Singh, Malkiat S Johal, and Cynthia R Selassie

Submissions from 2012

“A Rab-GEF cascade during human sperm exocytosis, MA Bustos, O Lucchesi, MC Ruete, LS Mayorga, Tomes and, and CN

Link

Utility of B-RAF DNA mutation in diagnosis and treatment of cancer, Dave S B Hoon

Link

Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer, Dave S B Hoon and Laurent Lessard

Submissions from 2011

Link

Treatment of cancer and compositions, Richard Essner

Link

Method and apparatus for in vivo collection of circulating biological components, Dave S B Hoon, Bret Taback, and Samuel Shaolian

Link

Method and apparatus for in vivo surveillance of circulating biological components, Dave S B Hoon, Bret Tabeck, and Samuel Shaolian

Submissions from 2009

Link

Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer, Dave S B Hoon and Michiel de Maat

Link

Use of ID4 for diagnosis and treatment of cancer, Dave S B Hoon and Naoyuki Umetani

Submissions from 2008

Link

Utility of B-RAF DNA mutation in diagnosis and treatment of cancer, Dave S B Hoon

Link

Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer, Dave S B Hoon and Michiel de Maat

Link

Utility of RET mutant in diagnosis and treatment of melanoma, Dave S B Hoon, Norihiko Narita, and Atsushi Tanemura

Link

Method and apparatus for in vivo surveillance of circulating biological components, Dave S B Hoon, Bret Taback, and Samuel Shaolian

Submissions from 2007

Link

Methylation of estrogen receptor alpha and uses thereof, Dave S B Hoon

Submissions from 2006

Link

Use of ID4 for diagnosis and treatment of cancer, Dave S B Hoon and Naoyuki Umetani

Submissions from 2005

Link

Detection of cancer cells in body fluids, Dave S B Hoon

Submissions from 2004

Link

DNA markers for management of cancer, Dave S B Hoon and Bret Taback

Link

Method and apparatus for in vivo collection of circulating biological components, Dave S B Hoon, Bret Taback, and Samuel Shaolian

Submissions from 2003

Link

Molecular lymphatic mapping of sentinel lymph nodes, Dave S B Hoon and Bret Taback

Link

Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR, Dave S B Hoon and Hiroya Takeuchi

Submissions from 2000

Link

Methods for lymph node identification, Donald L. Morton